ADH-6 TFA
ADH-6 TFA is a tripyridylamide compound that targets and dissociates mutant p53 aggregates in cancer cells. By disrupting the aggregation-nucleating subdomain, it reactivates p53 transcriptional function, leading to cell cycle arrest and apoptosis. This mechanism supports its application in cancer research, including in vitro studies on p53-aggregation related oncogenesis.
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation; Metabolism Research
Molecular Formula
C31H37F3N8O11
Molecular Weight
754.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7097556 Inquire
Recombinant Human Chloride channel CLIC-like protein 1 (CLCC1), partial
Sign In for Pricing
View Details 
bs-8034R-BF647 100 µL
COMMD1 Polyclonal Antibody, AbBy Fluor™ 647 Conjugated
Sign In for Pricing
View Details